Mitsubishi Chemical Group Corporation
Notice Regarding Change of Specified Subsidiary
Nippon Sanso Holdings' European subsidiary has acquired a Spanish home healthcare service company and made it a subsidiary as of March 3, 2026. Capital stock is 35.7 million euros.
Key Figures
- Acquisition Completion Date: 2026年3月3日
- Capital Stock of Acquiring Company: 35.7 million euros
- Sales of Acquired Company (Fiscal Year Ending December 2024): 40 million euros
AI要約
Overview of M&A
Nippon Sanso Holdings Co., Ltd. (NSHD), a consolidated subsidiary of Mitsubishi Chemical Group, completed the acquisition of shares in Esteve Teijin Healthcare, S.L., a Spanish home healthcare service company, through its European subsidiary Nippon Sanso Euro-Holding S.L.U.'s Spanish subsidiary Oximesa S.L.U. on March 3, 2026. After the acquisition, the company was renamed Nippon Sanso Homecare España, S.L.U., with capital stock of 35.7 million euros. A review of past capital transactions confirmed that the company qualifies as a specified subsidiary of Mitsubishi Chemical Group.
Future Outlook
The impact of this transaction has been incorporated into the full-year consolidated earnings guidance for the fiscal year ending March 2026, announced on February 5, 2026, and its effect on earnings has already been reflected. The acquisition is expected to strengthen the business base in the home healthcare service sector; however, detailed impact on financial results has not been disclosed.
Mitsubishi Chemical Group Corporation
Company overview · Stock price · Financial data · All IR
